Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)

CNY 8.14

(-0.25%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 2.87 Billion 2.97 Billion 2.78 Billion 2.5 Billion 1.56 Billion 1.45 Billion
Total Current Assets 1.86 Billion 2.06 Billion 1.92 Billion 2.02 Billion 1.13 Billion 1.02 Billion
Cash And Short Term Investments 1.19 Billion 1.28 Billion 1.2 Billion 1.39 Billion 576.79 Million 588.22 Million
Cash and Cash Equivalents 1.19 Billion 1.28 Billion 1.2 Billion 1.39 Billion 576.79 Million 588.22 Million
Short Term Investments - 33.32 Million - - 9.71 Million -40.87 Million
Net Receivables 625.06 Million 706.03 Million 677.49 Million 586.24 Million 529.26 Million 399.77 Million
Inventory 43.65 Million 40.52 Million 35.62 Million 36 Million 31.86 Million 32.03 Million
Other Current Assets 4.81 Million 33.32 Million 5.94 Million 7.42 Million 310.03 Thousand 114.42 Thousand
Total Non-Current Assets 1 Billion 906.81 Million 853.22 Million 474.12 Million 426.58 Million 439.21 Million
Net PPE 520.22 Million 409.13 Million 321.56 Million 255.73 Million 262.47 Million 326.71 Million
Good Will And Intangible Assets 86.35 Million 97.14 Million 116.47 Million 86.85 Million 75.43 Million 11.98 Million
Good Will - - - - - -
Intangible Assets 86.35 Million 97.14 Million 116.47 Million 86.85 Million 75.43 Million 11.98 Million
Long-Term Investments 288.49 Million 306.37 Million 327.86 Million 66.71 Million 18.35 Million 64.87 Million
Tax Assets 100.87 Million 85.9 Million 79.22 Million 62.97 Million 58.18 Million 31.19 Million
Other Non Current Assets 11.32 Million 8.26 Million 8.09 Million 1.84 Million 12.13 Million 4.43 Million
Other Assets - - - - - -
Total Liabilities 515.97 Million 722.98 Million 591.58 Million 492.21 Million 631.67 Million 466.07 Million
Total Current Liabilities 505.01 Million 673.34 Million 528.19 Million 427.92 Million 571.34 Million 454.72 Million
Account Payables 8.05 Million 7.43 Million 8.16 Million 5.26 Million 6.82 Million 4.77 Million
Tax Payables 1.61 Million 9.65 Million 29.71 Million 17.49 Million 36.3 Million 41.72 Million
Short Term Debt 6.32 Million 109.21 Million 8.67 Million 6.09 Million 152.97 Million 150 Million
Deferred Revenue 260.73 Thousand 308.92 Thousand 511.3 Million 410.47 Million 407.51 Million 41.72 Million
Other Current Liabilities 490.37 Million 556.38 Million 46.56 Thousand 6.09 Million 4.03 Million 258.21 Million
Total Non Current Liabilities 10.95 Million 49.64 Million 63.38 Million 64.28 Million 60.32 Million 11.35 Million
Long-Term Debt 10.95 Million 15.59 Million 22.58 Million 13.59 Million 2.12 Million -
Deferred Revenue Non Current 2.15 Million 34.04 Million 40.79 Million 50.68 Million 58.2 Million 11.35 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 2.15 Million 34.04 Million 40.79 Million 50.68 Million 58.2 Million -
Other Liabilities - - - - - -
Total Equity 2.35 Billion 2.25 Billion 2.18 Billion 2 Billion 933.14 Million 993.28 Million
Stock Holders Equity 2.35 Billion 2.25 Billion 2.19 Billion 2.01 Billion 931.52 Million 982.07 Million
Common Stock 103.65 Million 102.9 Million 104.3 Million 104.3 Million 92.3 Million 92.3 Million
Retained Earnings 918.31 Million 882.24 Million 816.27 Million 655.13 Million 569.22 Million 406.48 Million
Accumulated other comprehensive income 117.48 Million 119.96 Million 113.07 Million 51.37 Million 32.19 Million 32.14 Million
Common Stock Equity 2.35 Billion 2.25 Billion 2.19 Billion 2.01 Billion 931.52 Million 982.07 Million
Capital Lease Obligation 10.95 Million 23.81 Million 31.26 Million 19.69 Million 6.15 Million -
Total Investments 288.49 Million 306.37 Million 327.86 Million 66.71 Million 28.07 Million 24 Million
Total Debt 17.28 Million 124.81 Million 31.26 Million 19.69 Million 155.09 Million 150 Million
Net Debt -1.17 Billion -1.16 Billion -1.17 Billion -1.37 Billion -421.7 Million -438.22 Million

Balance Sheet Charts